Australia markets closed

Inspire Medical Systems, Inc. (INSP)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
248.35+13.12 (+5.58%)
At close: 04:00PM EDT
248.35 0.00 (0.00%)
After hours: 04:31PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 7.17B
Enterprise value 6.73B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)16.99
Price/book (mrq)14.46
Enterprise value/revenue 16.50
Enterprise value/EBITDA -165.17

Trading information

Stock price history

Beta (5Y monthly) 1.46
52-week change 3-0.49%
S&P500 52-week change 3-13.21%
52-week high 3282.31
52-week low 3142.74
50-day moving average 3254.85
200-day moving average 3218.32

Share statistics

Avg vol (3-month) 3305.93k
Avg vol (10-day) 3376.28k
Shares outstanding 529.13M
Implied shares outstanding 6N/A
Float 828.57M
% held by insiders 11.54%
% held by institutions 198.82%
Shares short (14 Mar 2023) 41M
Short ratio (14 Mar 2023) 43.14
Short % of float (14 Mar 2023) 43.90%
Short % of shares outstanding (14 Mar 2023) 43.44%
Shares short (prior month 14 Feb 2023) 41.22M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022


Profit margin -11.00%
Operating margin (ttm)-11.67%

Management effectiveness

Return on assets (ttm)-6.92%
Return on equity (ttm)-12.38%

Income statement

Revenue (ttm)407.86M
Revenue per share (ttm)14.53
Quarterly revenue growth (yoy)75.90%
Gross profit (ttm)341.74M
EBITDA -45.73M
Net income avi to common (ttm)-44.88M
Diluted EPS (ttm)-1.61
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)451.41M
Total cash per share (mrq)15.54
Total debt (mrq)8.87M
Total debt/equity (mrq)1.79
Current ratio (mrq)8.66
Book value per share (mrq)17.10

Cash flow statement

Operating cash flow (ttm)11.57M
Levered free cash flow (ttm)17.76M